Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Michael Emig | Researchclopedia

Back to researchers

Michael Emig

University of Mannheim

92

Works

5,506

Citations

21

h-index

30

i10-index

Research Topics

CAR-T cell therapy research Monoclonal and Polyclonal Antibodies Research Phagocytosis and Immune Regulation

Affiliations

Merck (Germany)2009–2009

Eli Lilly (United States)2020–2020

University of Mannheim2025–2025

Heidelberg University1996–2005

Western General Hospital2000–2000

Top Works

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial

H. Wilke,Kei Muro,et al.

20142,435 citations

Gastric Cancer Management and Outcomes

Colorectal Cancer Treatments and Studies

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial

Robert Pirker,Jose R. Pereira,et al.

20091,355 citations

Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR

Michael Emig,Susanne Saußele,et al.

1999269 citations

Molecular heterogeneity in complete cytogenetic responders after interferon-α therapy for chronic myelogenous leukemia: low levels of minimal residual disease are associated with continuing remission

Andreas Hochhaus,Andreas Reiter,et al.

2000184 citations

FLEX: A randomized, multicenter, phase III study of cetuximab in combination with cisplatin/vinorelbine (CV) versus CV alone in the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC)

Robert Pirker,A. Szczęsna,et al.

2008173 citations

Loss of <i>p53</i> impedes the antileukemic response to BCR-ABL inhibition

Hans‐Guido Wendel,Elisa de Stanchina,et al.

2006124 citations

Detection and quantification of residual disease in chronic myelogenous leukemia

Andreas Hochhaus,A Weißer,et al.

2000104 citations

RAINBOW: A global, phase III, randomized, double-blind study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in the treatment of metastatic gastroesophageal junction (GEJ) and gastric adenocarcinoma following disease progression on first-line platinum- and fluoropyrimidine-containing combination therapy rainbow IMCL CP12-0922 (I4T-IE-JVBE).

H. Wilke,Eric Van Cutsem,et al.

201492 citations

Subgroup analyses of the safety and efficacy of ramucirumab in Japanese and Western patients in RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer

Kohei Shitara,Kei Muro,et al.

201585 citations